JW (Cayman) Therapeutics Co Ltd
HKEX:2126

Watchlist Manager
JW (Cayman) Therapeutics Co Ltd Logo
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Watchlist
Price: 3.67 HKD 20.72% Market Closed
Market Cap: 1.5B HKD

Relative Value

The Relative Value of one JW (Cayman) Therapeutics Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 3.67 HKD, JW (Cayman) Therapeutics Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JW (Cayman) Therapeutics Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
27
vs Industry
64
Median 3Y
5.1
Median 5Y
4.7
Industry
7.5
Forward
4.3
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-1.7
Industry
23.6
Forward
-2.2
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.8
Industry
20.2
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-3.1
Industry
22.9
vs History
24
vs Industry
70
Median 3Y
0.5
Median 5Y
0.6
Industry
2.8
vs History
17
vs Industry
79
Median 3Y
-0.1
Median 5Y
-0.7
Industry
7.7
Forward
2.1
vs History
17
vs Industry
78
Median 3Y
-0.3
Median 5Y
-1.3
Industry
9.6
vs History
vs Industry
23
Median 3Y
0.1
Median 5Y
-0.3
Industry
4.9
Forward
-1.3
vs History
vs Industry
23
Median 3Y
0
Median 5Y
-0.2
Industry
4.9
Forward
-1.2
vs History
vs Industry
25
Median 3Y
0.1
Median 5Y
-0.3
Industry
5.4
vs History
vs Industry
22
Median 3Y
0.1
Median 5Y
-0.3
Industry
4
vs History
29
vs Industry
70
Median 3Y
-0
Median 5Y
0.1
Industry
5.1

Multiples Across Competitors

Competitors Multiples
JW (Cayman) Therapeutics Co Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
1.5B HKD 8.8 -2.4 -1.9 -1.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 139 238 -162 258.7 -197 033.9 -194 785.5
US
Abbvie Inc
NYSE:ABBV
338.1B USD 5.9 81.4 15.5 22.9
US
Amgen Inc
NASDAQ:AMGN
160.4B USD 4.7 27 14.5 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
135.5B USD 4.7 22.7 9.9 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD 10.7 -120.4 25.6 26.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 063.6 -526.6 -573.4 -558.1
AU
CSL Ltd
ASX:CSL
124.4B AUD 5.3 29.4 18.1 22.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.5B USD 4.2 13.2 11.8 13.3
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -61 -65.7 -59.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.3B USD 18 -156.9 -704 -352.8
P/E Multiple
Earnings Growth PEG
CN
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Average P/E: 34.8
Negative Multiple: -2.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 258.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.4
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.7
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -120.4 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -526.6 N/A N/A
AU
CSL Ltd
ASX:CSL
29.4
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -156.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Average EV/EBITDA: 15.9
Negative Multiple: -1.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 033.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.6
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -573.4 N/A N/A
AU
CSL Ltd
ASX:CSL
18.1
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -704 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Average EV/EBIT: 20.5
Negative Multiple: -1.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 785.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.9
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.9
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.8
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -558.1 N/A N/A
AU
CSL Ltd
ASX:CSL
22.6
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.3
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -352.8 N/A N/A